Recruiting
Phase 1

Cardiomyocyte Therapy

Sponsor:

Joseph C. Wu

Code:

NCT05068674

Conditions

Chronic Ischemic Left Ventricular Dysfunction

Eligibility Criteria

Sex: All

Age: 21 - 70+

Healthy Volunteers: Not accepted

Interventions

Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells

Human Embryonic Stem Cell-Derived Cardiomyocyte 150 cells

Human Embryonic Stem Cell-Derived Cardiomyocyte 300M cells

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Joseph C. Wu on 2024-10-18.